GL1X · GenesisL1 explorer

Research workbench

Co-crystal structure of KRAS (G12C) covalently bound with quinazoline based inhibitor JBI484

Analyse Co-crystal structure of KRAS (G12C) covalently bound with quinazoline based… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
5YXZ
Type
protein
Length
170 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
GTPase KRAS
UniProt
P01116
Ligands
GDP, 94C, MG
Pockets
1 · best druggability 0.64

Structure

x-ray diffraction · 1 distinct chain · 36% helix, 25% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AGTPase KRASprotein17036% helix, 25% strandP01116

Ligands and binding sites

  • GDP · Guanosine-5'-diphosphate · ligand · chains A
  • 94C · 1-[4-[6-chloranyl-8-fluoranyl-7-(2-fluorophenyl) quinazolin-4-yl]piperazin-1-yl]propan-1-one · ligand · chains A
  • MG · Magnesium ion · metal · chains A
  • EDO · 1,2-ethanediol · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12820.640.8143MG, GDP, 94C

Modifications

Observed in the structure: 1 covalent (covalent ligand).

Compared structures

  • 5YXZ · Co-crystal Structure of KRAS (G12C) covalently bound with Quinazoline based inhibitor… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.